Analysts: Endocyte Inc (ECYT.OQ)
ECYT.OQ on NASDAQ Stock Exchange Global Select Market
18.80USD
1 Aug 2013
18.80USD
1 Aug 2013
Price Change (% chg)
$0.83 (+4.62%)
$0.83 (+4.62%)
Prev Close
$17.97
$17.97
Open
$18.12
$18.12
Day's High
$18.86
$18.86
Day's Low
$18.03
$18.03
Volume
94,419
94,419
Avg. Vol
77,789
77,789
52-wk High
$18.86
$18.86
52-wk Low
$7.50
$7.50
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | -0.10 | December | 2 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 2 | 2 | 3 | 3 |
| (2) OUTPERFORM | 4 | 4 | 3 | 3 |
| (3) HOLD | 1 | 1 | 1 | 1 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.86 | 1.86 | 1.71 | 1.71 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 7 | 15.17 | 17.20 | 12.88 | 0.30 |
| Quarter Ending Dec-13 | 7 | 19.25 | 37.96 | 15.00 | 3.60 |
| Year Ending Dec-13 | 7 | 64.06 | 85.88 | 57.81 | 14.67 |
| Year Ending Dec-14 | 6 | 77.75 | 117.80 | 43.20 | 34.73 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 6 | -0.10 | -0.02 | -0.16 | -0.28 |
| Quarter Ending Dec-13 | 6 | -0.00 | 0.51 | -0.15 | -0.19 |
| Year Ending Dec-13 | 7 | -0.32 | 0.35 | -0.47 | -0.96 |
| Year Ending Dec-14 | 7 | -0.17 | 0.59 | -1.08 | -0.62 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 14.24 | 14.51 | 0.28 | 1.95 |
| Quarter Ending Dec-12 | 13.61 | 14.45 | 0.84 | 6.19 |
| Quarter Ending Sep-12 | 12.96 | 12.41 | 0.55 | 4.21 |
| Quarter Ending Jun-12 | 27.12 | 7.81 | 19.30 | 71.19 |
| Quarter Ending Mar-12 | 0.00 | 0.00 | 0.00 | 0.00 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 15.17 | 15.17 | 15.17 | 15.17 | 0.30 |
| Quarter Ending Dec-13 | 19.25 | 19.25 | 19.25 | 19.25 | 3.60 |
| Year Ending Dec-13 | 64.06 | 64.06 | 64.06 | 64.06 | 14.67 |
| Year Ending Dec-14 | 77.75 | 77.75 | 77.75 | 77.75 | 34.73 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-14 | 0 | 0 | 0 | 0 |
| Earnings | ||||
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: GlobalData
|
$250.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
|
Provider: Jefferson Research
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates